Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis ; volume:20 ; number:1 ; day:7 ; month:1 ; year:2019 ; pages:1-10 ; date:12.2019
BMC nephrology ; 20, Heft 1 (7.1.2019), 1-10, 12.2019
- Creator
-
Drozdz, Maciej
Weigert, André
Silva, Fatima
Frazão, João
Alsuwaida, Abdulkareem
Krishnan, Mahesh
Kleophas, Werner
Brzosko, Szymon
Johansson, Fredrik K.
Jacobson, Stefan H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-018-1196-7
- URN
-
urn:nbn:de:101:1-2019021101534157920317
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Drozdz, Maciej
- Weigert, André
- Silva, Fatima
- Frazão, João
- Alsuwaida, Abdulkareem
- Krishnan, Mahesh
- Kleophas, Werner
- Brzosko, Szymon
- Johansson, Fredrik K.
- Jacobson, Stefan H.
- SpringerLink (Online service)
Other Objects (12)
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement
Cardio renal anemia syndrome
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients
Hemodialysis patients’ preferences for the management of anemia
A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life
Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease
Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
Trends in anemia management in US hemodialysis patients 2004–2010
Optimizing anemia management using artificial intelligence for patients undergoing hemodialysis
Management guidelines for the treatment of renal anemia
Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement
Cardio renal anemia syndrome
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients
Hemodialysis patients’ preferences for the management of anemia
A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life
Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease
Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
Trends in anemia management in US hemodialysis patients 2004–2010
Optimizing anemia management using artificial intelligence for patients undergoing hemodialysis
Management guidelines for the treatment of renal anemia
Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement
Cardio renal anemia syndrome
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients
Hemodialysis patients’ preferences for the management of anemia
A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life
Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease
Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
Trends in anemia management in US hemodialysis patients 2004–2010
Optimizing anemia management using artificial intelligence for patients undergoing hemodialysis
Management guidelines for the treatment of renal anemia